Provided by Tiger Trade Technology Pte. Ltd.

ZHAOKE OPHTH-B

2.520
+0.0351.41%
Volume:166.10K
Turnover:415.16K
Market Cap:1.38B
PE:-5.64
High:2.520
Open:2.470
Low:2.470
Close:2.485
52wk High:4.210
52wk Low:2.380
Shares:549.00M
HK Float Shares:549.00M
Volume Ratio:0.58
T/O Rate:0.03%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.446
ROE:-13.89%
ROA:-8.82%
PB:0.85
PE(LYR):-5.64
PS:33.83

Loading ...

Kangda International Environmental Names Liew Fui Kiang Independent Non-executive Director

Reuters
·
Jun 29

Zhaoke Ophthalmology repurchases 1.56 million shares; issued share capital unchanged at 548.75 million

Bulletin Express
·
Jun 29

Zhaoke Ophthalmology buys back 1.30 million shares in June; total share count unchanged at 548.75 million

Bulletin Express
·
Jun 25

Zhaoke Ophthalmology-B Executes Share Buyback on June 23

Stock News
·
Jun 24

Zhaoke Ophthalmology buys back 1.29 million shares, utilises 2.34% of 2026 mandate

Bulletin Express
·
Jun 24

Zhaoke Ophthalmology-B's Four Buybacks Fail to Impress Market; What Could Drive a Rebound from Below Book Value?

Stock News
·
Jun 23

Zhaoke Ophthalmology-B Executes Share Buyback on June 22

Stock News
·
Jun 23

Zhaoke Ophthalmology Reports 1.16 Million-Share Buyback; Issued Share Capital Unchanged

Bulletin Express
·
Jun 23

Zhaoke Ophthalmology files HKEX next-day disclosure return on share repurchase for cancellation at HKD 2.54-2.54

Reuters
·
Jun 23

Lee's Pharmaceutical Announces Share Buyback Plan with HK$50 Million Cap

Stock News
·
Jun 16

Zhaoke Ophthalmology Buys Back 0.15% of Shares for HK$2.37 Million; Issued Share Capital Steady at 548.75 Million

Bulletin Express
·
Jun 16

Zhaoke Ophthalmology-B Executes Share Buyback, Spending Approximately HK$159,200

Stock News
·
Jun 16

Zhaoke Ophthalmology files HKEX next-day disclosure return on share repurchase for cancellation

Reuters
·
Jun 16

Zhaoke Ophthalmology's Application for Children's Myopia Drug Accepted in Australia

MT Newswires Live
·
Jun 15

Zhaoke Ophthalmology’s Low-Dose Atropine Eye Drops Cleared for Evaluation by Australia’s TGA

Bulletin Express
·
Jun 15

Zhaoke Ophthalmology-B Receives Australian Regulatory Submission Acceptance for Atropine Eye Drop Evaluation

Stock News
·
Jun 15

Zhaoke Ophthalmology - Ophth-B Atropine Sulfate Eye Drops Application Accepted for Evaluation by Australia's Tga

THOMSON REUTERS
·
Jun 15

Zhaoke Ophthalmology-B Executes Share Buyback on June 11

Stock News
·
Jun 11

Key Corporate Developments and Share Repurchases Highlight Hong Kong Market Activity

Stock News
·
Jun 09

Zhaoke Ophthalmology Approves Share Repurchase Plan Up To Hk$100 Million

Reuters
·
Jun 08